Sirolimus improves the prognosis of liver recipients with hepatocellular carcinoma: A single-center experience

Hepatobiliary & Pancreatic Diseases International(2023)

引用 2|浏览29
暂无评分
摘要
This study demonstrated that sirolimus significantly decreased HCC recurrence and prolonged RFS and OS in LT patients with different stage of HCC.
更多
查看译文
关键词
Hepatocellular carcinoma,Liver transplantation,Sirolimus,Tumor recurrence,Recurrence-free survival,Overall survival
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要